ATS 2024 Final Program

Click on the session title to view the speakers

202

MONDAY • MAY 20

Objectives At the conclusion of this session, the participant will be able to: • describe the association between race/ethnicity, social determinants of health and environmental stress with clinical outcomes in patients with chronic lung diseases • define new strategies in the management of minority patients affected by with chronic lung diseases • describe new findings of precision medicine, OMICS and deep phenotyping in minority patients afflicted by chronic lung diseases Disparities in respiratory medicine are common, and linked to social, economic, and environmental inequalities, affecting individuals of different backgrounds with different respiratory conditions. Here, we review different drivers of disparities and healthcare inequality, in respiratory medicine (race/ethnicity, social determinants of health, environmental stress, OMICS), differences on interpretation of diagnostic tests (oximetry, spirometry) or access to therapies (pulmonary rehabilitation), with case examples highlighting different chronic lung diseases such as asthma, sleep breathing disorders, pulmonary hypertension, COVID-19. We discuss future steps in the global task of assuring justice and equality in access to health care. 2:15 Addressing Race-Based Disparities in Respiratory Medicine - I 2:27 Addressing Race-Based Disparities in Respiratory Medicine - II 2:35 Race/Ethnicity as Drivers of Inequality: The Case of Pulse Oximetry 2:45 Spirometry Testing as a Driver of Disparity 2:55 Race/Ethnicity and Beyond: Advancing the Promise of Precision Medicine, OMICS, and Deep Phenotyping Across Respiratory Disease to Minorities 3:05 Barriers to Optimal Care: The Case of Pulmonary Rehabilitation 3:15 Traditional and Novel Social Determinants of Health: Insights from PAH 3:25 Environmental Stress and Disparities: Sleep Breathing Disorders 3:35 Role of Policy and Advocacy in Addressing Disparities This session and the International Conference are supported by independent medical educational grants from Boehringer IngelheimPharmaceuticals, Inc., Johnson&Johnson, Merck&Co., Inc., andUnitedTherapeuticsCorporation. All CMEsessions have been planned and implemented in accordancewith the AccreditationCriteria of theAccreditationCouncil for ContinuingMedical Education (ACCME ® ) and are free of the control of ineligible companies (formerly commercial interests).

the lung and how the two work in tandem to fight lung infection and disease. There are many papers assessing the contribution of macrophages or AEC2 cells to lung health and disease but few looking at the interactions and how the two work in tandem to respond to infection or injury. With the development of new cutting edge 3D models to assess macrophage epithelial cell interactions in the lung this session is timely and can also build on data generated from multi-omic approaches. 2:15 AT2-Derived GM-CSF: A Crucial Signal for Initiating and Sustaining Alveolar Macrophage Differentiation from Pre- to Postnatal Stages and into Adult 2:33 Forging an Antibacterial Alliance: How Legionella-Infected Macrophages Leverage Alveolar Epithelium to Metabolically Reprogram Myeloid Cells 2:51 Metabolic Signalling Unleashed: Unraveling the Role of Diverse Myeloid Cell Metabolism in Fibrotic Lung Disease. 3:09 Unveiling the Impact of Macrophage-Epithelial Paracrine Crosstalk in Viral Infection and Beyond 3:27 Unraveling the Path to COPD: Monocyte Extravasation and Alveolar Epithelial Cell Injury at the Crossroads of Disease Development BASIC • BEHAVIORAL • CLINICAL • TRANSLATIONAL SCIENTIFIC SYMPOSIUM B86 AN INCONVENIENT TRUTH: HEALTH DISPARITIES AND HEALTH CARE INEQUALITY IN RESPIRATORY MEDICINE Assemblies on Pulmonary Circulation; Allergy, Immunology and Inflammation; Behavioral Science and Health Services Research; Clinical Problems; Nursing; Pulmonary Infections and Tuberculosis; Pulmonary Rehabilitation; Respiratory Cell and Molecular Biology; Respiratory Structure and Function; Sleep and Respiratory Neurobiology; Council of Chapter Representatives Committee; Health Policy Committee 2:15 p.m. - 3:45 p.m. Marriott Marquis San Diego Marina Grand Ballroom 5-6 (Lobby Level, North Tower) Target Audience Cardiologists; General Medicine Physicians; Physicians in Training; Physician Assistant; Pulmonary Physicians, Registered Nurses.

ATS 2024 Conference Program • San Diego, CA